当前位置:首页 - 行情中心 - 未名医药(002581) - 财务分析

未名医药

(002581)

  

流通市值:37.79亿  总市值:62.21亿
流通股本:4.01亿   总股本:6.60亿

未名医药(002581)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.24亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益220499.91万元,未分配利润82749.40万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产229588.78万元,负债9088.87万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入314,710,263.52210,782,004.4683,804,783.29429,790,105.06
营业总成本348,197,159.44235,965,383.68106,361,412.35610,716,591.63
营业利润26,978,525.56-24,256,926.2-27,947,839.97-293,351,196.8
利润总额27,744,448.7-23,319,213.24-26,847,045.89-313,249,951.4
净利润24,001,834.01-24,814,640.42-27,055,340.81-322,135,112.27
其他综合收益----
综合收益总额24,001,834.01-24,814,640.42-27,055,340.81-322,135,112.27
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计721,882,905.32742,267,316.61508,532,507.81496,708,183.14
非流动资产合计1,574,004,935.81,527,146,426.131,747,414,709.821,840,429,765.89
资产总计2,295,887,841.122,269,413,742.742,255,947,217.632,337,137,949.03
流动负债合计64,554,239.7386,243,266.2875,844,964.49133,608,055.33
非流动负债合计26,334,502.329,812,557.7627,032,180.6729,803,542.4
负债合计90,888,742.03116,055,824.04102,877,145.16163,411,597.73
归属于母公司股东权益合计2,090,364,911.992,043,299,020.662,047,162,710.742,068,467,729.91
股东权益合计2,204,999,099.092,153,357,918.72,153,070,072.472,173,726,351.3
负债和股东权益合计2,295,887,841.122,269,413,742.742,255,947,217.632,337,137,949.03
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计331,802,571.5205,509,460.15103,266,237.28562,943,291.09
经营活动现金流出小计380,107,804.47256,144,238.25118,467,212.95599,449,495.29
经营活动产生的现金流量净额-48,305,232.97-50,634,778.1-15,200,975.67-36,506,204.2
投资活动现金流入小计297,953,576.7294,453,215.678,870,135.54260,968,001.15
投资活动现金流出小计3,536,594.35116,816.52122,925.074,318,774.96
投资活动产生的现金流量净额294,416,982.35294,336,399.0878,747,210.47256,649,226.19
筹资活动现金流入小计---13,837,591
筹资活动现金流出小计11,122,105.811,111,718.8293,362.37224,978,816.71
筹资活动产生的现金流量净额-11,122,105.81-1,111,718.82-93,362.37-211,141,225.71
汇率变动对现金及现金等价物的影响255.64274.43131.63-453.92
现金及现金等价物净增加额234,989,899.21242,590,176.5963,453,004.069,001,342.36
期末现金及现金等价物余额386,785,320.99394,385,598.37215,248,425.84151,795,421.78
TOP↑